SG3 Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Hold |
0
| – | – | – | 79 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 95 |
|
|
2022
Q1 | – | Sell |
-17,000
| Closed | -$2.88M | – | 257 |
|
|
2021
Q4 | $2.88M | Sell |
17,000
-23,250
| -58% | -$3.94M | 0.06% | 43 |
|
|
2021
Q3 | $7.6M | Buy |
40,250
+35,250
| +705% | +$6.66M | 0.23% | 6 |
|
|
2021
Q2 | $848K | Buy |
5,000
+1,000
| +25% | +$170K | 0.03% | 72 |
|
|
2021
Q1 | $565K | Buy |
+4,000
| New | +$565K | 0.01% | 128 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 274 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 236 |
|